Pharmacokinetics of human urinary kallidinogenase in rabbits and rats
- 1. Academy of Military Medical Sciences, Beijing (China). Inst. of Radiation Medicine
Description
Objective: To study the binding, degradation and concentration-time profiles of 125I-kallidinogenase in plasma after i.v. injection in rabbits. The distribution and excretion of kallidinogenase and its metabolites in urine and bile were also studied in rats. Methods: Using 125I-kallidinogenase combined with size-exclusive high performance liquid chromatography (SHPLC) or trichloroacetic acid precipitation method. Results: Determined by hydrolysis of chromogenic substrate (S-2266) of kallidinogenase, demonstrated that the enzymatic activity of 125I-kallidinogenase was similar to that of unlabelled enzyme. SHPLC analysis of plasma revealed that plasma protein bound 125I-kallidinogenase and 125I-degradation products were found after intravenous injection of various doses of the agent. Terminal half-lives of 125I-kallidinogenase-protein complex (AUC) after i.v. 5 x 10-3, 15 x 10-3, and 45 x 10-3 pNAu·kg-1 were (1.28 +- 1.31), (2.18 +- 1.08) and (2.03 +- 0.32) h, respectively. AUC increased with dose while clearance was similar. Maximal percentage of bound serum 125I-kallidinogenase in vitro was (94.3 +- 0.77)% and equilibrium dissociation constant (Kd) was 8.9 x 10-8 mol·L-1. Levels of acid precipitable radioactivity in different organs were in a descending order: urinary system, the highest blood abundant organs the next and cerebral cortex the lowest. (96.9 +- 3.3)% of injected radioactivity was excreted within 2 days and the major route was urinary system. Conclusions: 125I-kallidinogenase was rapidly bound to plasma protein with high affinity after i.v. injection. The pharmacokinetics of 125I-kallidinogenase was rapidly bound to plasma protein with high affinity after i.v. injection. The pharmacokinetics of 125I-kallidinogenase-protein complex was linear within dosage range studied in rabbits. 125I-kallidinogenase was mainly distributed in blood abundant organs, not able to across blood-brain barrier and excreted through urine after i.v. injection in rats
Additional details
Publishing Information
- Journal Title
- Chinese Journal of Nuclear Medicine
- Journal Volume
- 20
- Journal Issue
- 2
- Journal Page Range
- p. 82-85
- ISSN
- 0253-9780
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 32024665
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Descriptors DEI
- INJECTION; IODINE 125; KALLIKREIN; LABELLED COMPOUNDS; RABBITS; RADIONUCLIDE KINETICS; RATS
- Descriptors DEC
- ANIMALS; BETA DECAY RADIOISOTOPES; BLOOD COAGULATION FACTORS; COAGULANTS; DAYS LIVING RADIOISOTOPES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; ENZYMES; HEMATOLOGIC AGENTS; HYDROLASES; INTAKE; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; IODINE ISOTOPES; ISOTOPES; KINETICS; MAMMALS; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; PEPTIDE HYDROLASES; PROTEINS; RADIOISOTOPES; RADIOPROTECTIVE SUBSTANCES; RESPONSE MODIFYING FACTORS; RODENTS; SERINE PROTEINASES; VERTEBRATES